Omics technologies, including genomics, proteomics, and metabolomics, have opened new avenues in understanding the mechanisms of toxicity at a molecular level. These approaches allow researchers to observe how different chemicals affect biological pathways and identify biomarkers for early detection of toxic effects. This holistic view of biological responses to toxic substances is critical in personalized medicine, where individual genetic profiles can predict susceptibility to specific toxins, enabling tailored therapeutic interventions.
